Supplemental material
Emerging Microbes & Infections
Volume 10, 2021 - Issue 1
Research Article
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
, 
, , , , , , , , , , , , , , & show all
Noelia Casaresa Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain;c IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spainhttps://orcid.org/0000-0003-3817-6434View further author information
https://orcid.org/0000-0003-3817-6434View further author information, , Marta Ruiza Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain;b Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain;c IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spainhttps://orcid.org/0000-0002-8757-0932View further author information
https://orcid.org/0000-0002-8757-0932View further author information, , , , Gloria González-Aseguinolazaa Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain;c IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spainhttps://orcid.org/0000-0002-1600-4562View further author information
https://orcid.org/0000-0002-1600-4562View further author information, Cristian Smerdoua Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain;c IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spainhttps://orcid.org/0000-0002-6861-6579View further author information
https://orcid.org/0000-0002-6861-6579View further author information, Ascensión López-Díaz de Ceriod Clínica Universidad de Navarra, Pamplona, Spainhttps://orcid.org/0000-0002-7837-135XView further author information
https://orcid.org/0000-0002-7837-135XView further author information, , Felipe Prósperd Clínica Universidad de Navarra, Pamplona, Spain;e Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spainhttps://orcid.org/0000-0001-6115-8790View further author information
https://orcid.org/0000-0001-6115-8790View further author information, José R. Yusted Clínica Universidad de Navarra, Pamplona, Spainhttps://orcid.org/0000-0001-8502-9539View further author information
https://orcid.org/0000-0001-8502-9539View further author information, Francisco Carmona-Torred Clínica Universidad de Navarra, Pamplona, Spainhttps://orcid.org/0000-0002-8281-9583View further author information
https://orcid.org/0000-0002-8281-9583View further author information, Gabriel Reinad Clínica Universidad de Navarra, Pamplona, Spainhttps://orcid.org/0000-0003-4079-9753View further author information
https://orcid.org/0000-0003-4079-9753View further author information, Juan J. Lasartea Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain;c IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, SpainCorrespondence[email protected] [email protected]
https://orcid.org/0000-0003-1641-3881View further author information
https://orcid.org/0000-0003-1641-3881View further author information & Pablo Sarobea Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain;b Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain;c IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, SpainCorrespondence[email protected] [email protected]
https://orcid.org/0000-0003-0503-7905View further author information
https://orcid.org/0000-0003-0503-7905View further author information show allRelated Research Data
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Source:
Taylor & Francis
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Source:
Taylor & Francis
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Source:
Taylor & Francis
Linking provided by
